CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy.
Fontana M, Solomon SD, Kachadourian J, Walsh L, Rocha R, Lebwohl D, Smith D, Täubel J, Gane EJ, Pilebro B, Adams D, Razvi Y, Olbertz J, Haagensen A, Zhu P, Xu Y, Leung A, Sonderfan A, Gutstein DE, Gillmore JD.
Fontana M, et al. Among authors: smith d.
N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMoa2412309. Online ahead of print.
N Engl J Med. 2024.
PMID: 39555828